XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (12,968) $ (28,659)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation expense 2,687 3,695
Depreciation and amortization 2,837 2,781
Noncash operating lease cost 337 539
Amortization of premium (discount) on short-term investments (723) (390)
Noncash restructuring and other charges   1,204
Other 199 144
Changes in operating assets and liabilities    
Accounts receivable 6,385 (1,460)
Inventory and other deferred costs 1,707 262
Prepaid expenses and other assets (203) (254)
Accounts payable (5,637) (1,407)
Accrued and other current liabilities (7,836) 426
Contract liabilities (1,593) 4,999
Operating lease liabilities (840) 2,375
Net cash used in operating activities (20,413) (15,745)
Cash flows from investing activities:    
Purchases of available-for-sale debt securities (29,095) (21,529)
Proceeds from maturities of available-for-sale debt securities 35,500 39,100
Purchases of property and equipment (104) (3,778)
Net cash provided by investing activities 6,301 13,793
Cash flows from financing activities:    
Proceeds from sales of common stock under ATM facility, net of commissions 1,437  
Repayments of loans (308)  
Net cash provided by financing activities 1,129  
Effect of exchange rates on cash, cash equivalents and restricted cash (20) (4)
Net change in cash, cash equivalents and restricted cash (13,003) (1,956)
Cash, cash equivalents and restricted cash, beginning of period 58,774 90,918
Cash, cash equivalents and restricted cash, end of period 45,771 88,962
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:    
Cash and cash equivalents 43,981 87,172
Restricted cash, included in other long-term assets 1,790 1,790
Total cash, cash equivalents and restricted cash 45,771 $ 88,962
Tempus Warrants    
Adjustments to reconcile net loss to net cash used in operating activities    
Noncash gain related to liability $ (4,765)